These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

922 related articles for article (PubMed ID: 31074909)

  • 1. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
    Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
    J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.
    Hashimoto Y; Osaka T; Fukuda T; Tanaka M; Yamazaki M; Fukui M
    Endocr J; 2016 Oct; 63(10):877-884. PubMed ID: 27397679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
    Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
    Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.
    Hong HC; Hwang SY; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Hepatology; 2014 May; 59(5):1772-8. PubMed ID: 23996808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
    Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
    Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
    Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank.
    Freer CL; George ES; Tan SY; Abbott G; Scott D; Daly RM
    Calcif Tissue Int; 2024 Jun; 114(6):592-602. PubMed ID: 38678512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
    Kim G; Lee SE; Lee YB; Jun JE; Ahn J; Bae JC; Jin SM; Hur KY; Jee JH; Lee MK; Kim JH
    Hepatology; 2018 Nov; 68(5):1755-1768. PubMed ID: 29679374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
    Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
    J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
    da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
    Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.
    Zhang X; He Z; Si Q; Hu X; Yang L; Gu X; Du L; Wang L; Pan L; Li Y; Li J; Yang B; Gu X
    J Diabetes Res; 2022; 2022():2229139. PubMed ID: 36387941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the relationship between non-alcoholic fatty liver disease and sarcopenia in type 2 diabetes mellitus].
    Jiang H; Cheng QF; Zhu BZ; Yang Q
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):977-982. PubMed ID: 34814392
    [No Abstract]   [Full Text] [Related]  

  • 14. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
    Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
    Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myosteatosis in nonalcoholic fatty liver disease: An exploratory study.
    De Munck TJI; Verhaegh P; Lodewick T; Bakers F; Jonkers D; Masclee AAM; Verbeek J; Koek GH
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101500. PubMed ID: 32828745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria.
    Lera L; Albala C; Sánchez H; Angel B; Hormazabal MJ; Márquez C; Arroyo P
    J Frailty Aging; 2017; 6(1):12-17. PubMed ID: 28244552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
    J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between regional fat mass and risk of nonalcoholic fatty liver disease in overweight/obese adults].
    Zeng Y; Yuan S; Xie M; Xiao T; Huang Z; Zhou J; He Q; Yang Y; Ma J
    Wei Sheng Yan Jiu; 2022 Sep; 51(5):753-760. PubMed ID: 36222034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.
    Cabrera D; Ruiz A; Cabello-Verrugio C; Brandan E; Estrada L; Pizarro M; Solis N; Torres J; Barrera F; Arrese M
    Dig Dis Sci; 2016 Nov; 61(11):3190-3198. PubMed ID: 27572941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease.
    Kim HY; Baik SJ; Lee HA; Lee BK; Lee HS; Kim TH; Yoo K
    Sci Rep; 2020 Oct; 10(1):17491. PubMed ID: 33060775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.